Swedish national breast cancer guidelines recommend that all women diagnosed with breast cancer (BC) at the age of 35 years or younger should be referred to their regional oncogenetic clinic for genetic counseling and testing, regardless of family history of cancer. The main objective of this study was to evaluate whether place of residence at BC diagnosis and treating hospital were associated with the fact that not all BC patients diagnosed at ≤35 years in the southern part of Sweden have attended genetic counseling and testing. Between 2000 and 2013, 279 women in the South Swedish Health Care Region were diagnosed with BC at ≤35 years. Information regarding place of residence at BC diagnosis, treating hospital, time of registration and fi...
Genetic counselling and genetic testing of breast cancer patients can be helpful in estimating recur...
The aim of the study was to optimize the criteria for the BRCA1 and BRCA2 gene testing and to improv...
As part of a cluster randomised trial to assess an alternative model of cancer genetics services, we...
Swedish national breast cancer guidelines recommend that all women diagnosed with breast cancer (BC)...
Objective: The referral process for genetic counselling in breast cancer patients may be compromised...
Studies have shown that a significant number of eligible breast cancer patients are not offered gene...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Purpose: In Sweden, a Traceback approach, i.e., a retrospective genetic outreach activity, among can...
Germline TP53 mutations are associated with an increased risk of early-onset breast cancer. Traditio...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Background: In clinical routine, not every patient who is offered genetic counselling and diagnostic...
Certain ethnic groups seem to have less access to cancer genetic counseling. Our study was to invest...
Contains fulltext : 170974.pdf (publisher's version ) (Open Access)Certain ethnic ...
Certain ethnic groups seem to have less access to cancer genetic counseling. Our study was to invest...
Background: The main objectives of this study were to evaluate the concordance between self-reported...
Genetic counselling and genetic testing of breast cancer patients can be helpful in estimating recur...
The aim of the study was to optimize the criteria for the BRCA1 and BRCA2 gene testing and to improv...
As part of a cluster randomised trial to assess an alternative model of cancer genetics services, we...
Swedish national breast cancer guidelines recommend that all women diagnosed with breast cancer (BC)...
Objective: The referral process for genetic counselling in breast cancer patients may be compromised...
Studies have shown that a significant number of eligible breast cancer patients are not offered gene...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Purpose: In Sweden, a Traceback approach, i.e., a retrospective genetic outreach activity, among can...
Germline TP53 mutations are associated with an increased risk of early-onset breast cancer. Traditio...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Background: In clinical routine, not every patient who is offered genetic counselling and diagnostic...
Certain ethnic groups seem to have less access to cancer genetic counseling. Our study was to invest...
Contains fulltext : 170974.pdf (publisher's version ) (Open Access)Certain ethnic ...
Certain ethnic groups seem to have less access to cancer genetic counseling. Our study was to invest...
Background: The main objectives of this study were to evaluate the concordance between self-reported...
Genetic counselling and genetic testing of breast cancer patients can be helpful in estimating recur...
The aim of the study was to optimize the criteria for the BRCA1 and BRCA2 gene testing and to improv...
As part of a cluster randomised trial to assess an alternative model of cancer genetics services, we...